Leonard Reid 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Leonard Reid
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-30$1.56/sh+14,102$21,999→ 14,102 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-30−14,102→ 47,034 totalExercise: $1.56Exp: 2030-05-19→ Common Stock (14,102 underlying)
Holdings
- 122,157(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024.